Browse > Article

Inhibition of LPS-induced iNOS, COX-2 Expression and Cytokines Production by Fupenjic Acid in Macrophage Cells  

Yun, Chang-Hyeon (Department of pharmaceutical Biochemistry, College of Pharmacy, Kyung-Hee University)
Shin, Ji-Sun (Department of pharmaceutical Biochemistry, College of Pharmacy, Kyung-Hee University)
Park, Hee-Juhn (Division of Environmental Botany, Sangji University)
Park, Jong-Hee (College of Pharmacy, Pusan National University)
Lee, Kyung-Tae (Department of pharmaceutical Biochemistry, College of Pharmacy, Kyung-Hee University)
Publication Information
Korean Journal of Pharmacognosy / v.41, no.1, 2010 , pp. 14-20 More about this Journal
Abstract
In this study, we investigated the anti-inflammatory effects of fupenjic acid (FA) isolated from the Potentilla discolor in both RAW 264.7 and mouse primary peritoneal macrophage cells. FA pretreatment significantly inhibited nitric oxide (NO) and prostaglandin $E_2(PGE_2)$ productions in the lipopolysaccharide (LPS)-induced RAW 264.7 and mouse primary peritoneal macrophage cells. Consistent with these observations, Western blot and RT-PCR analyses revealed that FA inhibited the LPS-induced expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) at the protein and mRNA levels. In addition, FA reduced the release of tumor necrosis factor-$\alpha$ (TNF-$\alpha$) and interleukin-6 (IL-6). These results suggest that the down regulation of iNOS and COX-2 expression and TNF-$\alpha$ and IL-6 production by fupenjic acid are responsible for its anti-inflammatory effects.
Keywords
Fupenjic acid; LPS; Cytokines; iNOS; COX-2;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Hilliquin P, Borderie D, Hernvann A, Menkes CJ, Ekindjian OG. (1997) Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum. 40(8): 1512-1517   DOI   ScienceOn
2 Feldmann, M., Brennan, F. M. and Maini, R. N. (1996) Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14: 397-440.   DOI   ScienceOn
3 Karin, M. and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: the control of NF-B activity. Annu. Rev. Immunol. 18: 621-663.   DOI   ScienceOn
4 Hoffmann, J. A., Kafatos, F. C., Janeway, C. A. and Ezekowitz, R. A. (1999) Phylogenetic perspectives in innate immunity. Science 284: 1313-1318   DOI   ScienceOn
5 Janeway, C. A. Jr. and Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.   DOI   ScienceOn
6 Beutler, B. and Cerami, A. (1989) The biology of cachectin/TNF-R primary mediator of the host response. Annu. ReV. Immunol. 7: 625-655.   DOI   ScienceOn
7 Liu, S. F. and Malik, A. B. (2005) NF-$\kappaB$ activation as a pathological mechanism of septic shock and inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 290: L622-L645.
8 Nava, E., Palmer, R. M. and Moncada, S. (1992) The role of metric oxide in endotoxic shock: effects of NG-monomethyl-L-arginine. J. Cardiovasc. Pharmacol. 12: 132-134
9 Masferrer, J., Zweifel B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isacson, P. C. and Seibert, K. (1994) Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U.S.A. 91: 3228-3232.   DOI   ScienceOn
10 Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L. and Ksakson, P. (1994) Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A. 91: 12013-12017.   DOI   ScienceOn
11 Dendorfer, U. (1996) Molecular biology of cytokines. Artif. Organs. 20: 437-444.   DOI   ScienceOn
12 Stuehr, H. H. J., Kwon, N. S., Weise, M. and Nathan, C. (1991) Purification of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN- containing flavoprotein. Proc. Natl. Sci. USA. 88: 7773-7777.   DOI   ScienceOn
13 Syiem, D., Syngai G., Khup, P. Z., Khongwir. B. S., Kharbuli, B. and Kayang, H. (2002) Hypoglycemic effects of Potentilla fulgens L in normal and alloxan-induced diabetic mice. J. Ethnopharmacol. 83: 55-61.   DOI   ScienceOn
14 McCartney-Francis, N., Allen, J. B., Mizel, D. E., Albina, J. E., Xie, Q. W., Nathan, C. F. and Wahl, S. M. (1993) Suppression of arthritis by an inhibitor of nitic oxide synthase. J. Exp. Med. 178: 749-754.   DOI   ScienceOn
15 Weisz, A., Cicatiello, I. and Esumi, H. (1996) Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterical lipopolysaccharide and NG-monomethyl- L-arginene. Biochem. J. 316: 209-215.   DOI
16 Jie, Y., Xiao-Qing., C., Xiao-Xiao., L., Yuan, C., Mao-Xiang, L. and Qiang, W. (2008) Structural determination of two newtriterpenoids from Potentilla discolor Bunge by NMR techniques Magn. Reson. Chem. 46: 794-797   DOI   ScienceOn
17 Cho, W., Nam, J.-W., Kang, H.-J., Windono, T., Seo E.-K. and Lee, K.-T. (2009) Zedoarondiol isolated from the rhizoma of Curcuma heyneana is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines via the downregulation of NF-$\kappaB$ pathway in LPS-stimulated murine macrophages Int. Immunopharmacol. 9: 1049-1057   DOI   ScienceOn
18 Iontcheva, I., Amar, S., Zawawi, K. H., Kantarci, A. and Van Dyke, T. E. (2004). Role for moesin in lipopolysaccharide-stimulated signal transduction. Infect Immun. 72: 2312-2320.   DOI   ScienceOn
19 Zhao, C., Qiao, W., Zhang, Y. W., Lu, B. and Duan, H. Q. (2008) Study on anti-diabetes active fraction and constituents from Potentilla chinensis. Zhongguo Zhong Yao Za Zhi. 33: 680-682.
20 Xue, P. F., Zhao, Y. Y., Wang, B. and Liang, H. (2006) Secondary metabolites from Potentilla discolor Bunge (Rosaceae). Biochem. Syst. Ecol. 34: 825-828.   DOI   ScienceOn
21 Park, H.-J., Lee, k.-T. and Park, J.-H. (2007) Isolation of Two steroids and a triterpenoid from the roots of Potentilla discolor. Kor. J. Pharmacogn. 38: 354-357   과학기술학회마을
22 Tomczyk M, Latte KP. (2009) Potentilla--a review of its phytochemical and pharmacological profile. J. Ethnopharmacol. 122: 184-204   DOI   ScienceOn
23 Shoyakan (ed.) (1985) Encyclopedia of Chinese Medicinal Drugs, 2438-2438, Shanghai Science & Technology, Tokyo.